The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit

Am J Epidemiol. 2016 Mar 1;183(5):471-9. doi: 10.1093/aje/kwv299. Epub 2016 Feb 8.

Abstract

Carbapenem-resistant Enterobacteriaceae (CRE), a group of pathogens resistant to most antibiotics and associated with high mortality, are a rising emerging public health threat. Current approaches to infection control and prevention have not been adequate to prevent spread. An important but unproven approach is to have hospitals in a region coordinate surveillance and infection control measures. Using our Regional Healthcare Ecosystem Analyst (RHEA) simulation model and detailed Orange County, California, patient-level data on adult inpatient hospital and nursing home admissions (2011-2012), we simulated the spread of CRE throughout Orange County health-care facilities under 3 scenarios: no specific control measures, facility-level infection control efforts (uncoordinated control measures), and a coordinated regional effort. Aggressive uncoordinated and coordinated approaches were highly similar, averting 2,976 and 2,789 CRE transmission events, respectively (72.2% and 77.0% of transmission events), by year 5. With moderate control measures, coordinated regional control resulted in 21.3% more averted cases (n = 408) than did uncoordinated control at year 5. Our model suggests that without increased infection control approaches, CRE would become endemic in nearly all Orange County health-care facilities within 10 years. While implementing the interventions in the Centers for Disease Control and Prevention's CRE toolkit would not completely stop the spread of CRE, it would cut its spread substantially, by half.

Keywords: carbapenem-resistant Enterobacteriaceae; control measures; coordinated responses; regional spread; surveillance.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • California / epidemiology
  • Carbapenems / immunology
  • Centers for Disease Control and Prevention, U.S.
  • Computer Simulation
  • Cross Infection / epidemiology*
  • Cross Infection / prevention & control
  • Cross Infection / transmission
  • Drug Resistance, Bacterial
  • Enterobacteriaceae / drug effects
  • Enterobacteriaceae / immunology
  • Enterobacteriaceae Infections / epidemiology*
  • Enterobacteriaceae Infections / prevention & control
  • Enterobacteriaceae Infections / transmission
  • Forecasting
  • Health Facilities / trends*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Infection Control / methods*
  • Models, Theoretical
  • Population Surveillance / methods
  • Prevalence
  • United States / epidemiology

Substances

  • Carbapenems